BioSpace News Archive

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that it will host a Research & Development Day on June 1, 2023, beginning at 9 a.m. ET in New York City.

Akoya Biosciences, Inc. announced the launch of PhenoCode™ Discovery Panels, which simplify spatial biology workflows performed on the company’s PhenoCycler-Fusion platform, at the American Association for Cancer Research Annual Meeting being held in Orlando, Florida, April 14-19, 2023.

BPGbio, Inc. today announced that novel data insights from its oncology therapeutics and diagnostics portfolio will be presented at the American Association for Cancer Research (AACR) Annual Meeting in Orlando, April 14 – 19, 2023.

Mirum Pharmaceuticals, Inc. (“Mirum”) (Nasdaq: MIRM) today announced its intention to offer, subject to market and other conditions, $200.0 million aggregate principal amount of convertible senior notes due 2029 (the “notes”) in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”).

Oncolytics Biotech ® Inc. (NASDAQ: ONCY) (TSX: ONC) today announced that Chief Medical Officer Thomas Heineman , M.D., Ph.D., will participate in the Viral Immunotherapy – Moving Forward panel at Canaccord Genuity’s Horizons in Oncology Virtual Conference, which is taking place virtually on April 20, 2023.

Annalise.ai, the global radiology AI company, announced today that it has received FDA 510(k) clearances covering an additional seven findings as part of the company’s innovative AI-assisted triage and notification (CADt) solutions.

PDS Biotechnology Corporation announced it will host a Key Opinion Leader (KOL) Roundtable on Interleukin-12 (IL-12) for analysts, investors and the scientific community from 8:00 to 9:00 AM, ET on April 21, 2023.

Freeline Therapeutics Holdings plc announced that its Chief Executive Officer Michael Parini will present at the 22nd Annual Needham Virtual Healthcare Conference being held on April 17-20, 2023.

Cue Biopharma, Inc. announced today the appointment of industry veteran Patrick Verheyen to its board of directors (BOD).

Cybrexa Therapeutics, a clinical-stage oncology biotechnology company developing a novel class of tumor-targeting peptide drug conjugate therapeutics, announced the appointment of Jaya Gautam, Ph.D., as Senior Vice President, Technical Operations.